Differential COVID-19 infection rates in children, adults, and elderly: Systematic review and meta-analysis of 38 pre-vaccination national seroprevalence studies

SARS-CoV-2 antibody seroprevalence in Lebanon: findings from the first nationwide serosurvey

(2022) Abbas Hoballah et al.   BMC INFECTIOUS DISEASES

Structural racism and COVID-19 response: higher risk of exposure drives disparate COVID-19 deaths among Black and Hispanic/Latinx residents of Illinois, USA

(2022) Tobias M. Holden et al.   BMC PUBLIC HEALTH

Trend in Sensitivity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Serology One Year After Mild and Asymptomatic Coronavirus Disease 2019 (COVID-19): Unpacking Potential Bias in Seroprevalence Studies

(2022) Christopher R Bailie et al.   CLINICAL INFECTIOUS DISEASES

Incidence and seroprevalence of seasonal influenza a viruses in Egypt: Results of a community‐based cohort study

(2022) Mokhtar R. Gomaa et al.   Influenza and Other Respiratory Viruses

Nationally representative SARS-CoV-2 antibody prevalence estimates after the first epidemic wave in Mexico

(2022) Ana Basto-Abreu et al.   Nature Communications

School Closures During Social Lockdown and Mental Health, Health Behaviors, and Well-being Among Children and Adolescents During the First COVID-19 Wave

(2022) Russell Viner et al.   JAMA Pediatrics

Assessment of SARS-CoV-2 Seropositivity During the First and Second Viral Waves in 2020 and 2021 Among Canadian Adults

(2022) Xuyang Tang et al.   JAMA Network Open

Association between social isolation and reduced mental well-being in Swedish older adults during the first wave of the COVID-19 pandemic: the role of cardiometabolic diseases

(2022) Abigail Dove et al.   Aging-US

The end of the COVID‐19 pandemic

(2022) John P. A. Ioannidis   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Infection fatality rate of COVID-19 in community-dwelling elderly populations

(2022) Cathrine Axfors et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

COVID-19 prevalence and mortality in longer-term care facilities

(2022) Andrew T. Levin et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Seroprevalence of antibodies against SARS-CoV-2 in the adult population during the pre-vaccination period, Norway, winter 2020/21

(2022) Erik Eik Anda et al.   Eurosurveillance

Trends in social exposure to SARS-Cov-2 in France. Evidence from the national socio-epidemiological cohort–EPICOV

(2022) Josiane Warszawski et al.   PLoS One

COVID-19 seroprevalence in Pakistan: a cross-sectional study

(2022) Ahsan M Ahmad et al.   BMJ Open

Antibody Seroprevalence, Infection and Surveillance for SARS-CoV-2 in Residents and Staff of New Jersey Long-Term Care Facilities

(2022) Stephen M. Friedman et al.   JOURNAL OF COMMUNITY HEALTH

Comparison of pandemic excess mortality in 2020–2021 across different empirical calculations

(2022) Michael Levitt et al.   ENVIRONMENTAL RESEARCH

Age-stratified infection fatality rate of COVID-19 in the non-elderly population

(2022) Angelo Maria Pezzullo et al.   ENVIRONMENTAL RESEARCH

The Demography and Characteristic of SARS-CoV-2 Sero-positive Residents and Staff of Nursing Homes for Older Adults in the Community of Madrid: the SeroSOS Study

(2021) F J Candel et al.   AGE AND AGEING

Associations between measures of social distancing and SARS-CoV-2 seropositivity: a nationwide population-based study in the Netherlands

(2021) Eric R A Vos et al.   CLINICAL INFECTIOUS DISEASES

Seroprevalence of severe acute respiratory syndrome coronavirus 2 in Slovenia: results of two rounds of a nationwide population study on a probability-based sample, challenges and lessons learned

(2021) Mario Poljak et al.   CLINICAL MICROBIOLOGY AND INFECTION

Reconciling estimates of global spread and infection fatality rates of COVID‐19: An overview of systematic evaluations

(2021) John P. A. Ioannidis   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Nationwide seroprevalence of antibodies against SARS-CoV-2 in Israel

(2021) Shay Reicher et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

SARS-CoV-2 sero-prevalence among general population and healthcare workers in India, December 2020 - January 2021

(2021) Manoj V. Murhekar et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Severe Acute Respiratory Syndrome Coronavirus 2 Cumulative Incidence, United States, August 2020–December 2020

(2021) Patrick Sean Sullivan et al.   CLINICAL INFECTIOUS DISEASES

Prevalence of COVID-19 in Iran: results of the first survey of the Iranian COVID-19 Serological Surveillance programme

(2021) Kazem Khalagi et al.   CLINICAL MICROBIOLOGY AND INFECTION

Prevalence of SARS-CoV-2 antibodies in Denmark: nationwide, population-based seroepidemiological study

(2021) Laura Espenhain et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Penetration and impact of COVID-19 in long term care facilities in England: population surveillance study

(2021) Dimple Y Chudasama et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

The fall in antibody response to SARS-CoV-2: a longitudinal study of asymptomatic to critically ill patients up to 10 months after recovery

(2021) Maddalena Peghin et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Undiagnosed SARS-CoV-2 seropositivity during the first 6 months of the COVID-19 pandemic in the United States

(2021) Heather Kalish et al.   Science Translational Medicine

SARS-CoV-2 Seroprevalence Structure of the Russian Population during the COVID-19 Pandemic

(2021) Anna Y. Popova et al.   Viruses-Basel

Effect of socioeconomic inequalities and vulnerabilities on health-system preparedness and response to COVID-19 in Brazil: a comprehensive analysis

(2021) Rudi Rocha et al.   Lancet Global Health

Longitudinal SARS‐CoV‐2 seroprevalence in Portugal and antibody maintenance 12 months after infection

(2021) Luísa Canto e Castro et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

The Study to Investigate COVID-19 Infection in People Living in Ireland (SCOPI): A seroprevalence study, June to July 2020

(2021) Laura Heavey et al.   Eurosurveillance

Age, COVID-19-like symptoms and SARS-CoV-2 seropositivity profiles after the first wave of the pandemic in France

(2021) Fabrice Carrat et al.   INFECTION

Seroprevalence of SARS-CoV-2 antibodies in the general population of Oman: results from four successive nationwide sero-epidemiological surveys

(2021) Seif Salem Al-Abri et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Age-seroprevalence curves for the multi-strain structure of influenza A virus

(2021) Dao Nguyen Vinh et al.   Nature Communications

Safeguarding people living in vulnerable conditions in the COVID-19 era through universal health coverage and social protection

(2021) Gabriela Cuevas Barron et al.   Lancet Public Health

A three-phase population based sero-epidemiological study: Assessing the trend in prevalence of SARS-CoV-2 during COVID-19 pandemic in Jordan

(2021) Saverio Bellizzi et al.   One Health

Change in age distribution of COVID-19 deaths with the introduction of COVID-19 vaccination

(2021) Roberta Pastorino et al.   ENVIRONMENTAL RESEARCH

Impact of Coronavirus Disease 2019 on Geriatric Psychiatry

(2021) Azziza Bankole   PSYCHIATRIC CLINICS OF NORTH AMERICA

SeroTracker: a global SARS-CoV-2 seroprevalence dashboard

(2020) Rahul K Arora et al.   LANCET INFECTIOUS DISEASES

Factors associated with COVID-19-related death using OpenSAFELY

(2020) Elizabeth J. Williamson et al.   NATURE

Novel coronavirus epidemic in the Hungarian population, a cross-sectional nationwide survey to support the exit policy in Hungary

(2020) Béla Merkely et al.   GeroScience

Population-level COVID-19 mortality risk for non-elderly individuals overall and for non-elderly individuals without underlying diseases in pandemic epicenters

(2020) John P.A. Ioannidis et al.   ENVIRONMENTAL RESEARCH

Humoral Immune Response to SARS-CoV-2 in Iceland

(2020) Daniel F. Gudbjartsson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Covid-19: Group of UK and US experts argues for “focused protection” instead of lockdowns

(2020) Jeanne Lenzer   BMJ-British Medical Journal

Inferring Influenza Infection Attack Rate from Seroprevalence Data

(2014) Joseph T. Wu et al.   PLoS Pathogens